AccuStem Sciences, Inc.: AccuStem Sciences Announces Extensi

LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today

Related Keywords

Phoenix , Arizona , United States , London , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Risk Factor In Accustem Sciences Inc , Trademark Office , Exchange Commission , Accustem Sciences Inc , Stem Sciences , Chief Executive Officer , Risk Factor , Accustem Sciences , Annual Report , Chief Operations , Chief Executive , Accustem , Ciences , Nnounces , Extension , Patent , Application , Spare , Pest , Patients , Breast , Dancer ,